Microinterventional endocapsular nuclear fragmentation assisted cataract surgery versus conventional phacoemulsification using divide-and-conquer: a randomized controlled trial

Microinterventional endocapsular nuclear fragmentation assisted cataract surgery versus conventional phacoemulsification using divide-and-conquer: a randomized controlled trial - miLOOP trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON53956

Enrollment

Registered

2023-01-31

Start date

2023-04-03

Completion date

Unknown

Last updated

2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract hard nucleus

Interventions

Microinterventional endocapsular nuclear fragmentation.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age >= 18 years. Best corrected visual acuity < 0.2 (Snellen). Advanced visually significant nuclear sclerosis grade >= 5 (LOCS III).

Exclusion criteria

Exclusion criteria: Endothelial cell density (ECD) < 1500 mm-2. Corneal opacification (any cause). Corneal surgery or trauma.

Design outcomes

Primary

Measure	Time frame
Cumulative dispersed ultrasound energy (CDE) and endothelial cell loss.	—

Secondary

Measure	Time frame
Procedural time, adverse events, visual acuity.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)